Comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3 Methylglutaric Aciduria C3151952
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Endogenous Maternal Derived Androgen and 3 Methylglutaric Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3 Methylglutaric Aciduria C3151952
An organic acidemia affecting how the body processes certain amino acids. It can cause neurological problems and metabolic crises. Management involves dietary changes and supportive treatment.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3 Methylglutaric Aciduria C3151952
0-10
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3 Methylglutaric Aciduria C3151952
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3 Methylglutaric Aciduria C3151952
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3 Methylglutaric Aciduria C3151952
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3 Methylglutaric Aciduria C3151952
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3 Methylglutaric Aciduria C3151952
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3-methylglutaric-aciduria-C3151952 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3 Methylglutaric Aciduria C3151952 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | Atypical genital development may be present in an XX infant. | Genital development is not the defining feature in available data. | High |
| Metabolic or neurologic episodes | Not described as a metabolic crisis disorder. | May involve neurologic problems and metabolic crises. | High |
| Primary body system | Reproductive and endocrine features predominate. | Metabolic processing of certain amino acids is affected. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 when
XX infant with atypical genitalia and suspected maternal androgen exposure
The supplied description centers on placental transfer of maternal hormones.
Moderate
Need for pediatric endocrine or DSD specialist assessment
Management is described as involving pediatric specialists and possible hormone therapy.
Moderate
No evidence of organic acidemia
Absence of metabolic features makes the aciduria less aligned, but does not prove the DSD.
Low
Choose 3 Methylglutaric Aciduria C3151952 when
Child with suspected organic acidemia
The description specifies impaired processing of certain amino acids.
Moderate
Neurologic problems with metabolic decompensation
These features are stated for 3-methylglutaric aciduria, not the DSD.
Moderate
Need for dietary and supportive metabolic care
Management is described as dietary change plus supportive treatment.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3 Methylglutaric Aciduria C3151952 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | Relevant to confirming an XX chromosomal pattern. | Not the defining test in the supplied description. | A chromosomal result supports classification but does not alone prove maternal androgen cause. |
| Organic acid or metabolic testing | No characteristic abnormality is established here. | May show findings consistent with an organic acidemia if clinically indicated. | Abnormal metabolites are results requiring metabolic specialist interpretation, not an automatic diagnosis. |
| Maternal and infant endocrine evaluation | May be used to investigate androgen exposure. | Not the primary evaluation described. | Exact cutoffs and required panels are not established by these source data. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- Outcome
- A chronic congenital condition; specific outcomes are not established here.
- Factors
- Specialist care and individual anatomy or endocrine findings may influence course.
3 Methylglutaric Aciduria C3151952
- Outcome
- A chronic metabolic disorder with possible neurologic problems and crises.
- Factors
- Dietary management, supportive care, and crisis prevention may matter; effect size is unknown.
Time frame: Both are described as chronic; onset is variable for the DSD and childhood-associated for the aciduria.
Prognosis cannot be individualized from these sparse source data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental or identity-related concerns | Atypical sex development may require long-term specialist support. Not described as the main complication. Psychosocial needs vary and should be individualized. |
| Neurologic impairment | Not established from the supplied description. Neurologic problems may occur. Severity and permanence are not quantified here. |
| Acute metabolic crisis | Not a stated feature. Metabolic crises are described as possible. Triggers, frequency, and outcomes are not specified. |
Patient education highlights
- HighDifferent conditions
One concerns fetal sex development from maternal hormones; the other concerns amino-acid metabolism.
- HighSpecialist care
Pediatric endocrine or DSD care, or metabolic care, should guide testing and treatment decisions.
- MediumAvoid unsupported numbers
Prevalence, laboratory cutoffs, doses, and mortality are not established by this comparison.